Skip to content

Study of Tomography of Nephrolithiasis Evaluation

Randomized Controlled Trial of Ultrasound Versus CT (Computed Tomography) for Patients in the Emergency Department With Suspected Renal Colic

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01451931
Acronym
STONE
Enrollment
2776
Registered
2011-10-14
Start date
2011-09-30
Completion date
2013-09-30
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

kidney stone, urolithiasis, urinary tract infection, ultrasound, computed tomography, safety, cost, accuracy

Brief summary

This is a multi-center, randomized controlled trial of ultrasonography (ultrasound) compared to computed tomography (CT) for the initial emergency room evaluation of patients with suspected renal colic. The investigators will compare several measures of effectiveness including morbidity related to the patient's underlying disease, or complications related to delayed diagnosis, patient status regarding pain/missed days of work, and utilization of health care resources based on one of three study arms: ultrasound in the Emergency Department, ultrasound in Radiology or CT.

Detailed description

This is a multi-center, randomized controlled trial of ultrasonography compared with computed tomography (CT) for the evaluation of patients with suspected urolithiasis. The study will be conducted at 15 large urban Emergency Departments (EDs), reflecting geographic, socioeconomic, racial and ethnic diversity, and include academic medical centers as well as safety net hospitals. The patients will be randomized to one of three arms: 1) ultrasound in the Emergency Department (ED), 2) ultrasound in radiology or 3) CT in radiology. The investigators will then collect precise and unbiased data on a comprehensive range of outcomes that will allow assessment of effectiveness, safety, accuracy and cost between patients randomized to one the three groups. Taken together, these measures are intended to provide the basis for a valid comparison of imaging of patients with suspected urolithiasis seen in the ED. The results of this trial could lead to a change in clinical practice that is associated with both improved patient outcomes and reduced cost. Broad stakeholder involvement from within radiology, emergency medicine and several subspecialty communities has been sought to ensure the strategic completion of study aims and to help rapidly disseminate the results of the study into clinical practice. This will create a collaborative network of EDs willing to act as a laboratory for studying the comparative effectiveness of diagnostic testing. As a result, the proposed trial will demonstrate the feasibility of conducting Randomized Control Trials (RCTs) of imaging that incorporates measurements of outcomes that can be expanded to additional imaging tests in the future.

Interventions

OTHERPoint-of-care Ultrasound

Perform ultrasonography in the ED (physician).

RADIATIONRadiology Ultrasound

Diagnostic ultrasound completed in the radiology department at time 0.

OTHERRadiology CT

Computed tomography of abdomen completed in the radiology department at time 0.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* men or women = or \>18 but \<76 years of age presenting with acute renal colic * Emergency department physician highly suspects a primary diagnosis of kidney stones (renal colic) or the patient requires imaging to rule out kidney stones.

Exclusion criteria

* children \< 18 years old * elderly patients \> or = 76 years old * pregnancy or planning pregnancy * Morbid obesity (\>285 pounds in men, \>250 pounds in women) * patients with an acute abdomen, signs of sepsis, signs of alternate diagnosis (ie appendicitis, abdominal aortic aneurysm, pyelonephritis, kidney stones not suspected). * history of kidney problems (hemodialysis, kidney transplant, presence of only one kidney)

Design outcomes

Primary

MeasureTime frameDescription
High Risk Diagnosis With Complication30 days from baselineMissed or delayed diagnosis of appendicitis, pneumonia with sepsis, diverticulitis, abdominal aortic aneurysm with rupture, mesenteric ischemia with bowel perforation, renal infarction, stone with renal abscess, urosepsis/pyelonephritis with bacteremia, ovarian torsion with necrosis related to randomization and due to imaging modality.
Cumulative Radiation ExposureBaseline plus 6 months post-baseline

Secondary

MeasureTime frame
ED Length of StayBaseline visit excluding hospitalization
Return Visits to ED or Hospital6 months post-baseline
Accuracy for Stones by ArmUp to 6 month follow-up for stone passage

Countries

United States

Participant flow

Participants by arm

ArmCount
Point-of-care Ultrasound
Patient with suspected urolithiasis received ultrasonography performed in the emergency department. Ultrasonography in the Emergency Department: Perform ultrasonography in the ED (physician).
908
Radiology Ultrasound
Patient with suspected urolithiasis received diagnostic ultrasonography in the radiology department. Diagnostic ultrasonography in radiology department: Diagnostic ultrasound completed in the radiology department at time 0.
893
Computed Tomography
Patient with suspected urolithiasis received computed tomography in the radiology department. CT in Radiology: Computed tomography of abdomen completed in the radiology department at time 0.
958
Total2,759

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up173621
Overall StudyWithdrawal by Subject162222

Baseline characteristics

CharacteristicTotalPoint-of-care UltrasoundRadiology UltrasoundComputed Tomography
Age, Categorical
<=18 years
21 Participants4 Participants5 Participants12 Participants
Age, Categorical
>=65 years
66 Participants16 Participants22 Participants28 Participants
Age, Categorical
Between 18 and 65 years
2672 Participants888 Participants866 Participants918 Participants
Age, Continuous40.4 years
STANDARD_DEVIATION 12.7
40.1 years
STANDARD_DEVIATION 12.4
40.4 years
STANDARD_DEVIATION 12.8
40.7 years
STANDARD_DEVIATION 12.8
Ethnicity (NIH/OMB)
Hispanic or Latino
668 Participants218 Participants224 Participants226 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2075 Participants685 Participants663 Participants727 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
16 Participants5 Participants6 Participants5 Participants
History of Kidney Stones or Cancer
No Kidney Stone
1610 number of participants531 number of participants508 number of participants571 number of participants
History of Kidney Stones or Cancer
Prior Kidney Stones
1149 number of participants377 number of participants385 number of participants387 number of participants
Race (NIH/OMB)
American Indian or Alaska Native
38 Participants12 Participants8 Participants18 Participants
Race (NIH/OMB)
Asian
125 Participants35 Participants39 Participants51 Participants
Race (NIH/OMB)
Black or African American
690 Participants236 Participants213 Participants241 Participants
Race (NIH/OMB)
More than one race
88 Participants32 Participants33 Participants23 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
6 Participants1 Participants1 Participants4 Participants
Race (NIH/OMB)
Unknown or Not Reported
16 Participants5 Participants6 Participants5 Participants
Race (NIH/OMB)
White
1796 Participants587 Participants593 Participants616 Participants
Region of Enrollment
United States
2759 participants908 participants893 participants958 participants
Self-Reported Pain Score8.1 units on a scale
STANDARD_DEVIATION 2.2
8.3 units on a scale
STANDARD_DEVIATION 2
8.0 units on a scale
STANDARD_DEVIATION 2.4
8.1 units on a scale
STANDARD_DEVIATION 2.2
Sex: Female, Male
Female
1331 Participants443 Participants416 Participants472 Participants
Sex: Female, Male
Male
1428 Participants465 Participants477 Participants486 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
110 / 90892 / 893101 / 958
serious
Total, serious adverse events
3 / 9084 / 8935 / 958

Outcome results

Primary

Cumulative Radiation Exposure

Time frame: Baseline plus 6 months post-baseline

ArmMeasureValue (MEAN)Dispersion
Point-of-care UltrasoundCumulative Radiation Exposure10.1 mSvStandard Deviation 14.1
Radiology UltrasoundCumulative Radiation Exposure9.3 mSvStandard Deviation 13.4
Computed TomographyCumulative Radiation Exposure17.2 mSvStandard Deviation 13.4
Primary

High Risk Diagnosis With Complication

Missed or delayed diagnosis of appendicitis, pneumonia with sepsis, diverticulitis, abdominal aortic aneurysm with rupture, mesenteric ischemia with bowel perforation, renal infarction, stone with renal abscess, urosepsis/pyelonephritis with bacteremia, ovarian torsion with necrosis related to randomization and due to imaging modality.

Time frame: 30 days from baseline

ArmMeasureValue (NUMBER)
Point-of-care UltrasoundHigh Risk Diagnosis With Complication6 participants
Radiology UltrasoundHigh Risk Diagnosis With Complication3 participants
Computed TomographyHigh Risk Diagnosis With Complication2 participants
Secondary

Accuracy for Stones by Arm

Time frame: Up to 6 month follow-up for stone passage

ArmMeasureGroupValue (NUMBER)
Point-of-care UltrasoundAccuracy for Stones by ArmSensitivity85 Percent probability
Point-of-care UltrasoundAccuracy for Stones by ArmSpecificity50 Percent probability
Radiology UltrasoundAccuracy for Stones by ArmSensitivity84 Percent probability
Radiology UltrasoundAccuracy for Stones by ArmSpecificity53 Percent probability
Computed TomographyAccuracy for Stones by ArmSensitivity86 Percent probability
Computed TomographyAccuracy for Stones by ArmSpecificity53 Percent probability
Secondary

ED Length of Stay

Time frame: Baseline visit excluding hospitalization

ArmMeasureValue (MEDIAN)
Point-of-care UltrasoundED Length of Stay5.1 Hours
Radiology UltrasoundED Length of Stay6.4 Hours
Computed TomographyED Length of Stay6.3 Hours
Secondary

Return Visits to ED or Hospital

Time frame: 6 months post-baseline

ArmMeasureGroupValue (NUMBER)
Point-of-care UltrasoundReturn Visits to ED or HospitalNumber of return visits to ED231 Number of visits
Point-of-care UltrasoundReturn Visits to ED or HospitalNumber of hospital readmissions87 Number of visits
Radiology UltrasoundReturn Visits to ED or HospitalNumber of return visits to ED231 Number of visits
Radiology UltrasoundReturn Visits to ED or HospitalNumber of hospital readmissions84 Number of visits
Computed TomographyReturn Visits to ED or HospitalNumber of return visits to ED255 Number of visits
Computed TomographyReturn Visits to ED or HospitalNumber of hospital readmissions83 Number of visits

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026